Last reviewed · How we verify
NCT05882500: PtitStudien
Osteopontin as a Biomarker in Pancreatitis
trial testing No intervention, observation in Pancreatitis in 103 participants. Completed in 31 January 2023.
19 October 2016
Quick facts
| Lead sponsor | Linkoeping University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 103 |
| Start date | 3 March 2011 |
| Primary completion | 19 October 2016 |
| Estimated completion | 31 January 2023 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- No intervention, observation
Conditions studied
- Pancreatitis — all drugs for Pancreatitis →
Sponsor
Linkoeping University
Who can join
18 and older, any sex, with Pancreatitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In the early phase of pancreatits, factors that can give information about the development of severety are still lacking. In this study patients will be included prospectively upon the diagnosis of pancreatits and clinical as well as labarotory and radiological factors will be sampled. The aim is do identifiy factors that may aid in the risk stratification for development of different severity grades of pancreatitis.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Plasma Osteopontin Reflects Tissue Damage in Acute Pancreatitis.
Wirestam L, Nyberg PB, Dzhendov T, Gasslander T, et al · · 2023 · cited 6× · PMID 37371722 · DOI 10.3390/biomedicines11061627
Verify or expand the search:
- PubMed search for NCT05882500
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pancreatitis
Currently open trials in the same condition.
- NCT07083063 — Precise Endoscopic Application of Nitroglycerin in Preventing Post-ERCP Pancreatitis · Phase 4 · recruiting
- NCT07262957 — Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Inc · Phase 4 · recruiting
- NCT07012772 — COMBO Endoscopy Oropharyngeal Airway in Sedated Endoscopic Retrograde Cholangiopancreatography for Patients · Phase 2 · recruiting
- NCT07051980 — Feasibility and Safety of Supraglottic Oxygen Delivery Via an Endotracheal Tube for Non-intubated ERCP Anesthesia: A Two · Phase 2 · recruiting
- NCT07071441 — Indomethacin vs Diclofenac for Preventing PEP · NA · recruiting
Other Linkoeping University trials
Trials by the same sponsor.
- NCT07494422 — A Path to Prevention of Elder Abuse in Long-term Care. Prevalence Study Among Staff in Long-term Care. · not yet recruiting
- NCT07485439 — Self-inspired & Tailored Autism Movement With Phystic App · NA · enrolling by invitation
- NCT07391540 — ICBT for Psychological Symptoms Related to Economy · NA · recruiting
- NCT07181213 — Genetic Predisposition to High Blood Pressure · NA · enrolling by invitation
- NCT07312136 — MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05882500 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Linkoeping University
- Last refreshed: 31 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05882500.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing